Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026
-
Fury as US federal agents search anti-Trump lawmaker's home
-
US Open champ Zverev to become tennis world number one
-
One goal enough for Flick as Barca enter Galatasaray cauldron
-
Migrant crisis wounds unhealed in Ceuta as Spanish royals visit
-
A7 to unveil a service that will re-invent the international payments market
-
Brazilian judge allows Flavio Bolsonaro to visit jailed father
-
'Status quo' with EU 'not good enough', UK PM says as summit date set
-
France braces for fresh student demonstrations as Macron calls for 'respect'
-
Stolen Renoir paintings found behind wall in France
-
Zelensky doubtful on Russian acceptance of Trump's 'energy ceasefire'
-
French supermarkets suffer refrigerator shutdown after 'unprecedented' cyberattack
-
Federal agents search home of Trump critic Ilhan Omar: government
-
Arsenal lose Hincapie and Zubimendi in freak double blow
-
Pakistan detains hundreds from ex-PM Khan's party as protests falter
-
Saudi says resilience tested, vows response after deadly airport attacks
-
Australia's Smith off field after being struck on helmet
-
Alcaraz exits Shanghai Masters in straight-sets loss
-
UK retains early access to test latest US AI models
-
Pope to enter hospital on Tuesday for lung operation
-
Top NATO commander warns Russia any attack would be 'futile'
-
Renshaw shines again before Australia declaration
-
Stolen Renoir paintings found behind wall in France: prosecutor
-
Atletico's Simeone encourages goalless Alvarez improvement
-
UNHCR sounds alarm on funding crisis
-
FXGLOBE Rebuilds Its Copy Trading and PAMM Business With B2BROKER's B2COPY
-
French supermarket chains say cyberattack forced refrigerator shutdown
-
Nepal rescuers search for missing after flash flood
-
Minister's resignation rocks German coalition
-
Oil rises as Trump comments roil energy markets
-
Hurricane Simon lashes Mexico's Pacific coast, threatens landfall
-
Premier League in limbo as Manchester City soar
-
France schools protest rumbles on as Macron urges 'respect'
-
Zelensky vows to respond as Moscow silent on 'energy ceasefire'
-
Americans Hall and Woodford win economics Nobel for stabilisation models
-
Thousands march in India's capital to demand election chief resign
-
MEXC Brings AI, TradFi and the Future of Trading to Life at TOKEN2049 Singapore
-
African players in Europe: Mbeumo ends goal drought as United draw
-
Italian rice farmer beats heat with biodiversity haven
-
France's high school students plan fresh protests
-
Stocks mixed as oil prices slip after Trump hails 'energy ceasefire'
-
NZ bank in free speech row over 'explicit' sheep memes
-
Opposition, journalists allege police abuses during India protests
-
China Open champ Zheng withdraws from Wuhan citing fatigue
-
DATA Network joins Sui and Walrus to scale the supply chain for AI training data
-
Brewers edge Dodgers 2-1 in National League Championship Series opener
-
Melbourne man linked to suspected flydubai hijacker condemns 'false accusations'
-
Pope to have surgery to remove lung nodule
-
North Korea fires 'several ballistic missiles' into Sea of Japan
-
Stocks rise as oil prices tumble after Trump hails 'energy ceasefire'
-
El Nino sets temperature record in key Pacific zone: EU monitor
Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026
CAMBRIDGE, MA / ACCESS Newswire / July 9, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, July 31, 2026 to report its second quarter 2026 financial results, and provide a corporate update.
A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.
Webcast: https://investors.modernatx.com
The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
F.Bennett--AMWN
